Resource Library
All resources
Filter By

A marathoner’s journey shaped by whole-person support
Jenni Joined Vida Health in January 2025, looking to improve her health and build sustainable habits that fit into her life.

GLP-1s changed everything, but what are the risks behind the reward?
GLP-1s are not over-the-counter supplements. They are chronic disease medications with real physiological consequences. Yet, the care infrastructure around them has not kept pace with the prescribing volume, nor does it consider potential risk factors.

GLP-1s were meant for chronic disease. How did they become a cosmetic trend?
If solving the obesity crisis was just about dropping pounds, with the help of GLP-1s, we’d have already accomplished that task. But, weight loss is more than a checked box or renewed prescription. It’s a lifestyle change.

Erica Terry’s Transformation Through Sustainable Behavior Change
Conversations about weight loss often center on diets, medications, or the number on the scale. But for our very own Erica Terry, Director of Sales, Payer/PBM at Vida Health, the most important lesson was much simpler and far more powerful…

Why precision matters in obesity care
Over the past several years, obesity care has entered a new era of clinical sophistication…

The case for a new standard in metabolic health measurement
For decades, body mass index (BMI) has served as the shorthand for defining obesity and, by extension, metabolic health…

The Viewpoint from Vida: where does AI fit into healthcare?
AI in telehealth must be governed by the principle of “do no harm” and must serve, not shape, care. AI improves care by reducing clinical workflow friction and streamlining data among other benefits however, when it comes to healthcare where do we have a responsibility to be sure humans are calling the shots?

The Viewpoint from Vida: what happens after GLP-1s?
Whether or not someone continues GLP-1 therapy is a clinical decision that should be made in partnership with their healthcare provider. But what are the strategic benefits, and what are the risks?

MASH: The hidden driver of rising costs and cardiometabolic risk
MASH is one of the fastest-growing and most overlooked drivers of metabolic risk and rising healthcare costs.

Making GLP-1s Work: Rethinking Access and Affordability
For plan sponsors, the decisions made today will shape costs, outcomes, and member trust for years to come. A smarter strategy blends access, affordability, and clinical excellence rather than forcing tradeoffs.

Dr. Kelly Henkler on Compassionate Obesity Care, Real Support, and the Future of Healthspan
At Vida, we know our medical team is at the heart of everything we do. In this new series, we’re spotlighting the physicians, dietitians, and coaches who bring their expertise and compassion to every member interaction. Each profile highlights their unique journeys, the impact they’ve made helping members manage chronic conditions, and the knowledge they bring to advancing evidence-based care.

Dr. Dan Passerman on Leading with Compassion, Whole-Person Care, and the Future of Obesity Treatment
At Vida, we know our medical team is at the heart of everything we do. In this new series, we’re spotlighting the physicians, dietitians, and coaches who bring their expertise and compassion to every member interaction. Each profile highlights their unique journeys, the impact they’ve made helping members manage chronic conditions, and the knowledge they bring to advancing evidence-based care.